Effect of Butorphanol on Colonoscopy for Patients With Postoperative Visceral Pain
Status:
Completed
Trial end date:
2021-09-30
Target enrollment:
Participant gender:
Summary
The total incidence of abdominal pain after colonoscopy is almost 50%. Butorphanol is a mixed
opioid receptor agonist-antagonist, which has strong sedative and analgesic effects. This
clinical study aims to explore the effectiveness and safety of butorphanol combined with
propofol for colonoscopy to reduce postoperative visceral pain, and provide a basis for
improving the quality of surgery and comfortable medical treatment for patients.